Research Article
Mild Adrenal Steroidogenic Defects and
ACTH-Dependent Aldosterone Secretion in High Blood
Pressure: Preliminary Evidence
João Martin Martins,
1,2
Sónia do Vale,
1,2
and Ana Filipa Martins
1,2
1
Endocrine Department, Hospital Santa Maria and Lisbon Medical School, Professor Egas Moniz Avenue, 1649-028 Lisbon, Portugal
2
Servic ¸o de Endocrinologia, Hospital de Santa Maria, Piso 6, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal
Correspondence should be addressed to Jo˜ ao Martin Martins; jmartinmartins@sapo.pt
Received 13 September 2014; Revised 11 November 2014; Accepted 13 November 2014; Published 15 December 2014
Academic Editor: Andre P. Kengne
Copyright © 2014 Jo˜ ao Martin Martins et al. his is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Introduction. Adrenal glands play a major role in the control of blood pressure and mild defects of steroidogenesis and/or
inappropriate control of mineralocorticoid production have been reported in high blood pressure (HBP). Patients and Methods. We
used a speciic protocol for the evaluation of 100 consecutive patients with inappropriate or recent onset HBP. Speciic methods were
used to conirm HBP and to diagnose secondary forms of HBP. In addition we tested adrenal steroidogenesis with the common
cosyntropin test, modiied to include the simultaneous measurement of renin and aldosterone besides 17-hydroxyprogesterone
(17OHP) and 11-deoxycortisol (S). Results. Secondary forms of HBP were diagnosed in 32 patients, including 14 patients with
primary hyperaldosteronism (PA) (14%) and 10 patients with pheochromocytoma (10%). Mild defects of the 21-hydroxylase
(21OHD) and 11-hydroxylase (11OHD) enzymes were common (42%). ACTH-dependent aldosterone secretion was found in most
patients (54%) and characteristically in those with mild defects of adrenal steroidogenesis (>60%), PA (>75%), and otherwise in
patients with apparent essential HBP (EHBP) (32%). Discussion. Mild defects of adrenal steroidogenesis are common in patients
with HBP, occurring in almost half of the patients. In those patients as well as in patients with apparent EHBP, aldosterone secretion
is commonly dependent on ACTH.
1. Introduction
HBP occurs in more than 25% of the adult western population
and is a major determinant of mortality, with cardio- and
cerebrovascular disease accounting for 30–50% of all deaths
[1].
Until recently, HBP was assumed to be idiopathic in
over 90% of the cases, and the search for the etiology was a
futile clinical exercise in most instances [2]. As an example
of changing medical paradigms, secondary forms of HBP,
mainly PA, are now considered to account for up to 15% of
all cases [3].
Adrenal glands play a major direct role in water and salt
balance, mineralocorticoids and glucocorticoids, and in heart
output and vascular tone, catecholamines; they are therefore
a major determinant of blood pressure levels in normal
conditions [3–5]. Speciic adrenal diseases like PA, Cushing’s
syndrome, pheochromocytoma, and some cases of congenital
adrenal hyperplasia (CAH) and glucocorticoid-remediable
aldosteronism (GRA) are well recognized forms of secondary
HBP [1–7]; however, except for PA, all are deemed to be very
rare.
A more general involvement of the adrenals may occur
in HBP. Recent research identiies mild defects of the inal
steps of glucocorticoid and/or mineralocorticoid synthesis,
namely, defects of the 11-hydroxylase enzyme and abnormal
control of aldosterone secretion, ACTH-dependent aldos-
terone secretion, as common and related phenomena in
patients with HBP [8–12]. We tested adrenal steroidogenesis
and mineralocorticoid production, using the common cosyn-
tropin test, modiied to include the measurement of renin
and aldosterone, besides cortisol, 17OHP, and S, in patients
Hindawi Publishing Corporation
International Journal of Endocrinology
Volume 2014, Article ID 295724, 8 pages
http://dx.doi.org/10.1155/2014/295724